Last update 08 May 2025

Autologous bone marrow mononuclear cells(Cellonis Biotechnology)

Overview

Basic Info

Drug Type
Cell therapy
Synonyms-
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Immune System DiseasesEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Diabetes Mellitus, Type 1
Originator Organization
Beijing Cellonis Gene Biotechnology Co., Ltd.Beijing Cellonis Gene Biotechnology Co., Ltd.
Active Organization-
Inactive Organization
Beijing Cellonis Gene Biotechnology Co., Ltd.Beijing Cellonis Gene Biotechnology Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Autologous bone marrow mononuclear cells(Cellonis Biotechnology)
EUCTR2009-017924-18-NL
/ Not yet recruitingNot Applicable
Efficacy assessment of repeat intramyocardial injection of autologous bone marrow cells in previously responding no-option patients with residual refractory angina pectoris and documented ischemia - Repeat cell therapy for refractory angina
NCT01143168
/ Unknown statusPhase 1
A Pilot Study on Transplantation Therapy Using Autologous Bone Marrow Mononuclear Cells and Umbilical Cord Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus
EUCTR2009-016364-36-NL
/ Not yet recruitingNot Applicable
Injection of Autologous Bone Marrow Cells into Damaged Myocardium of No-option Patients with Ischemic Heart Failure: a randomized placebo controlled trail. - Cell therapy for ischemic heart failure
100 Clinical Results associated with Autologous bone marrow mononuclear cells(Cellonis Biotechnology)
Login to view more data
100 Translational Medicine associated with Autologous bone marrow mononuclear cells(Cellonis Biotechnology)
Login to view more data
100 Patents (Medical) associated with Autologous bone marrow mononuclear cells(Cellonis Biotechnology)
Login to view more data
100 Deals associated with Autologous bone marrow mononuclear cells(Cellonis Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Diabetes Mellitus, Type 1Phase 1
China
Beijing Cellonis Gene Biotechnology Co., Ltd.Beijing Cellonis Gene Biotechnology Co., Ltd.
01 Aug 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free